Short answer
Protagonist Therapeutics, Inc (PTGX) filed an 8-K current report with the SEC on February 25, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Q4 and full year 2025 earnings reported February 25, 2026.
Protagonist Therapeutics, Inc 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q4 and full year 2025 earnings reported February 25, 2026
- Full results and financial details contained in the furnished press release exhibit: key figures not disclosed in this item text
- PTGX coverage period: fiscal year ended December 31, 2025
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Protagonist Therapeutics, Inc 8-K filings
Get the next PTGX 8-K as it lands
Follow PTGX for push alerts, or ask the research agent what this filing means.